Kuang Xinzhu, Li Wei, Kanno Yuichiro, Yamashita Naoya, Nemoto Kiyomitsu, Asada Yoshihisa, Koike Kazuo
Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba, 274-8510, Japan.
Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
J Nat Med. 2016 Jan;70(1):120-6. doi: 10.1007/s11418-015-0940-6. Epub 2015 Sep 28.
The discovery of new drugs that target cancer stem cells (CSCs) is a critical approach to overcome the major difficulties of the metastasis, chemotherapeutic resistance and recurrence for successful cancer therapy. Chemical investigation of the roots of Euphorbia fischeriana resulted in the isolation of eight ent-atisane diterpenoids (1-8), including two new compounds: 19-O-β-D-glucopyranosyl-ent-atis-16-ene-3,14-dione (7) and 19-O-(6-galloyl)-β-D-glucopyranosyl-ent-atis-16-ene-3,14-dione (8). The structures were elucidated on extensive spectroscopic analyses, as well as chemical transformations. ent-3β-Hydroxyatis-16-ene-2,14-dione (5), 7 and its aglycon, ent-19-hydroxy-atis-16-ene-3,14-dione (7a), showed significant inhibitory activity on mammosphere formation in human breast cancer MCF-7 cells at a final concentration of 10 μM.
发现靶向癌症干细胞(CSCs)的新药是克服癌症转移、化疗耐药性和复发等重大难题以实现成功癌症治疗的关键途径。对狼毒大戟根进行化学研究,从中分离出8种对映-贝壳杉烷二萜(1-8),包括两种新化合物:19-O-β-D-吡喃葡萄糖基-对映-贝壳杉-16-烯-3,14-二酮(7)和19-O-(6-没食子酰基)-β-D-吡喃葡萄糖基-对映-贝壳杉-16-烯-3,14-二酮(8)。通过广泛的光谱分析以及化学转化确定了其结构。对映-3β-羟基贝壳杉-16-烯-2,14-二酮(5)、7及其苷元对映-19-羟基-贝壳杉-16-烯-3,14-二酮(7a)在终浓度为10μM时,对人乳腺癌MCF-7细胞的乳腺球形成表现出显著的抑制活性。